Pfizer news from FierceHealthcare
News
Trial data on Neurontin may have been manipulated
A new paper published in the New England Journal of Medicine has accused drugmaker Pfizer of manipulating clinical data on trials of anti-seizure drug Neurontin (gabapentin). The accusations stem... Read more...
Pfizer pays $2.3B penalty for off-label drug marketing
Pfizer has agreed to pay a mammoth $3.2 billion penalty for marketing off-label uses of several of its drugs, a settlement which the U.S. Department of Justice has labeled the largest healthcare... Read more...
Coming into the home stretch, pharma spends big on lobbying
With health reform set for one of the biggest remakes in U.S. history, it's little wonder that health players are spending big bucks on lobbying Capitol Hill. But of all the moneyed healthcare... Read more...
Drugmaker rebates short-circuit impact of health plan co-pays
In theory, the co-pay system is supposed to encourage smart shopping without sacrificing patients' health. Patients pay higher portions of the bill--sometimes more than double--for pricier branded... Read more...
Case study: Miami drug reps not registering as lobbyists
Right now, sentiment is high on Capitol Hill to expose the money flowing to doctors from pharmaceutical and medical device companies. A look at what's happening in some markets right now, however,... Read more...
Baystate Medical subpeonaed for anesthesiologist's records
Federal investigators are now digging into the financial records of a Massachusetts anesthesiologist and former head of the acute pain unit at Baystate Medical Center in Springfield. Dr. Scott Reuben... Read more...
MA anesthesiologist accused of fabricating 21 studies
While we at FierceHealthcare have covered all kinds of allegations regarding skulduggery in the research business, particularly questionable behavior that advances pharmaceutical company interests.... Read more...
Government plans investigation of devicemaker kickbacks to surgeons
Federal health officials and prosecutors are mounting an investigation designed to identify doctors how accept kickbacks from drug and devicemakers for using their products. The investigation focuses... Read more...
Grassley investigates Pfizer's financial ties to Harvard Med School MDs
Sen. Charles Grassley (R-IA) continues with his campaign to address pharma influence in medicine, this time with a letter to Pfizer asking about its financial relationship with doctors at Harvard... Read more...
Medtronic plans disclosure of doctors getting $5K-plus annually
Medical devicemaker Medtronic has become the latest of a string of companies agreeing to voluntarily disclose their payments to physicians. Starting in March 2011, the company plans to begin... Read more...
